$ALXO 3 SEC Filings

Filed On	Filing
17 Apr 2026	Form 3: Knight Jeff E., Chief Dev & Operating Officer No securities owned
05 Mar 2026	Form 3: Klencke Barbara, Chief Medical Officer Holds 60,000 shares of Common Stock
13 Aug 2025	Form 3: Curran Daniel J., Director No securities owned
23 Jan 2025	Form 3: Takimoto Chris H, Director No securities owned
23 Jan 2025	Form 3: Klencke Barbara, Director Holds 60,000 shares of Common Stock
23 Jan 2025	Form 3: Shantharam Harish, Chief Financial Officer No securities owned
07 Aug 2024	Form 3: Sandler Alan B., Director No securities owned
29 Nov 2022	Form 3: Garland J. Scott, Director No securities owned
14 Apr 2022	Form 3: Canamasas Itziar, Director No securities owned
05 May 2021	Form 3: Pinto Shelly, VP, Finance and CAO No securities owned
16 Jul 2020	Form 3: Lsv Associates, Llc, 10% owner and 7 others
16 Jul 2020	Form 3: Adelman Robert J, 10% owner and 6 others Holds 151 shares of Common Stock
16 Jul 2020	Form 3: Vivo Capital IX, Llc, 10% owner and 1 other
16 Jul 2020	Form 3: Graham G. Walmsley, Director
16 Jul 2020	Form 3: Nielsen Jack, Director No securities owned
16 Jul 2020	Form 3: Lettmann Jason, Director
16 Jul 2020	Form 3: Hemrajani Rekha, Director
16 Jul 2020	Form 3: Goodman Corey S, Director Holds 151 shares of Common Stock
16 Jul 2020	Form 3: Randolph Sophia, Chief Medical Officer Holds 208,524 shares of Common Stock
16 Jul 2020	Form 3: Pietzke Steffen, VP Fin & Chief Acct Officer

Comments